Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 649 of 6351
-
A game may help teens with HIV stick to treatment
Disease control CompletedThis is a cluster-randomized controlled trial that aims to conduct comprehensive feasibility testing of a smartphone game in a sample of 120 adolescents living with HIV (ALHIV) ages 15-21 in Kisumu, Kenya, to determine whether the game influences behavioral mediators of engagemen…
Sponsor: Emory University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for heart lining pain: can CardiolRx keep flare-ups away?
Disease control Recruiting nowMulti-center, randomized, double-blind, placebo-controlled, phase-3 Trial. Patients with a history of recurrent pericarditis who are being treated with an IL-1 blocker for at least 12 months, scheduled to be discontinued, will be approached for potential trial participation. Dou…
Phase 3 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New shigella vaccine shows promise for infants in phase 2 trial
Vaccine CompletedIn this study, the second-generation tetravalent bioconjugate candidate vaccine Shigella4V2 will be tested to confirm data on its safety and immunogenicity in infants and to identify the best dose of Shigella4V2 in 9-month-old infants.
Phase 2 • Sponsor: LimmaTech Biologics AG • Aim: Vaccine
Last updated Aug 09, 2026 00:00 UTC
-
New drug cocktail aims to save bladders in cancer fight
Disease control Recruiting nowPatients with MIBC will receive 3 cycles (C1-C3) of induction enfortumab vedotin plus pembrolizumab followed by restaging including MRI of the bladder, urine cytology, and cystoscopy with TURBT of any visible tumor and/or resection site plus random biopsies using a recommended te…
Phase 2 • Sponsor: Matthew Galsky • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
One shot gene therapy could end monthly eye injections for wet AMD
Disease control OngoingVAN-2401 is Phase I clinical trial to assess the safety and tolerability of KH658 in subjects with neovascular AMD. KH658 is gene therapy designed to deliver a protein which targets and blocks VEGF via an adeno-associated viral vector. The standard of care for patients with neova…
Phase 1 • Sponsor: Chengdu Origen Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Handheld ultrasound + AI could bring breast cancer screening to remote areas
Diagnosis OngoingThe high cost of diagnostic equipment, limited expertise, and inadequate infrastructure are major barriers to early breast cancer diagnosis in low- and middle-income countries. Point-of-care ultrasound (POCUS) offers a relatively low-cost, portable solution that, when combined wi…
Sponsor: Region Skane • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Can a common muscle relaxant make radiation deadlier for rectal cancer?
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of papaverine (PPV) when given together with radiation therapy (RT) and tests how well it works in treating patients with rectal cancer that has spread to nearby tissue or lymph nodes (locally advanced). PPV is an enzyme i…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a simple gas help heal the brain after injury?
Disease control By invitation onlyTraumatic brain injury (TBI) causes acute deficits in cerebral perfusion which may lead to secondary injury and worse outcomes. Inhaled nitric oxide (iNO) is a vasodilator that increases cerebral blood flow and is clinically used for hypoxic respiratory failure in neonates and ad…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple ear clip tame brain swelling after a stroke?
Disease control Recruiting nowThis study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following intracerebral hemorrhage.
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New radiation schedule tested to improve esophageal cancer treatment
Disease control Recruiting nowThis is a prospective, open-label, randomized phase II clinical trial designed to compare the efficacy and toxicity of hypofractionated concurrent chemoradiotherapy versus conventional fractionated concurrent chemoradiotherapy following induction chemoimmunotherapy in patients wi…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a double nerve block silence the deep pain after bariatric surgery?
Symptom relief Completedafter laparoscopic bariatric surgery, visceral pain (VP) remains a significant issue. VP causes autonomic symptoms, such as nausea and vomiting, and does not respond to conventional pain management methods that target incisional pain. The present study was performed to test the e…
Sponsor: Alexandria University • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Can a simple blood test predict leukemia risk after cancer therapy?
Knowledge-focused Recruiting nowThe goal of the Clonal Hematopoiesis Chemotherapy and Radiation Effects (CH CARE) Study is to understand how the presence or absence of clonal hematopoiesis (CH) influences outcomes in people receiving chemotherapy and radiation for solid cancers. The study will collect biospeci…
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New pill could let Sun-Sensitive patients enjoy the outdoors
Disease control OngoingThe goal of this clinical trial is to learn if bitopertin works and is safe to treat EPP or XLP in participants 12 years or older. The main questions it aims to answer are: * Whether bitopertin increases pain-free sunlight exposure after 6 months of treatment in participants wit…
Phase 3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a daily pill douse the Sun's pain for people with EPP?
Symptom relief CompletedA Phase 2a study of PORT-77 in adults with erythropoietic protoporphyria (EPP)
Phase 2 • Sponsor: Portal Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can a Family-Based program reduce depression and abuse in young nepali wives?
Disease control Recruiting nowIntimate Partner Violence (IPV) is a major public health problem in low- and middle-income countries (LMICs). Globally, an estimated 30% of women report physical or sexual violence by an intimate partner in their lifetime. IPV is a well-established social driver of mental health …
Sponsor: Possible • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug shows promise for Hard-to-Treat uterine and cervical cancers
Disease control Recruiting nowThe researchers are doing this study to find out if ivonescimab is an effective treatment for people with endometrial cancer (EC) and/or cervical cancer (CC). The researchers will also look at whether the study drug is safe and causes few or mild side effects in participants.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Promising new shingles vaccine enters human trials
Vaccine Recruiting nowThe purpose of this clinical study is to evaluate the safety and immunogenicity of receiving two doses of recombinant herpes zoster vaccine (CHO cells) (RHZV) in healthy individuals aged 40 years and above. This study will be conducted in 2 substudies: Substudy A (Phase I) and Su…
Phase 1/2 • Sponsor: Shanghai Institute Of Biological Products • Aim: Vaccine
Last updated Jun 27, 2026 08:08 UTC
-
Shockwave therapy could crack tough heart blockages
Disease control Recruiting nowThe FORWARD CAD IDE Study is a Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study conducted to assess the safety and effectiveness of the Shockwave Intravascular Lithotripsy (IVL) System with the Javelin Coronary IVL Catheter for the treatment of c…
Sponsor: Shockwave Medical, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Immune cell therapy takes on untreatable liver cancer
Disease control OngoingThis is a Phase 1b study of GKL-006 Injection in patients with unresectable hepatocellular carcinoma.
Phase 1 • Sponsor: Beijing Gene Key Life Technology Co., Ltd • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a diabetes drug stop AFib from coming back?
Disease control Recruiting nowObjective: The purpose of this study is to determine if there is a difference in the recurrence rate of atrial fibrillation (AF) between a group of patients with AF and heart failure undergoing catheter ablation who are administered the SGLT2 inhibitor, Enavogliflozin, and a cont…
Phase 4 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC